RB
Richmond Brothers Portfolio holdings
AUM
$153M
This Quarter Return
+5.5%
1 Year Return
+15.91%
3 Year Return
+117.95%
5 Year Return
–
10 Year Return
–
AUM
$50.6M
AUM Growth
+$50.6M
(-6.3%)
Cap. Flow
-$5.53M
Cap. Flow
% of AUM
-10.93%
Top 10 Holdings %
Top 10 Hldgs %
92.1%
Holding
26
New
2
Increased
3
Reduced
11
Closed
4
Top Buys
| 1 |
DURECT Corp
DRRX
|
$392K |
| 2 |
Heron Therapeutics
HRTX
|
$209K |
| 3 |
Alvotech
ALVO
|
$170K |
| 4 |
ProShares UltraPro QQQ
TQQQ
|
$130K |
| 5 |
SoFi Technologies
SOFI
|
$66.6K |
Top Sells
| 1 |
ARK Innovation ETF
ARKK
|
$1.58M |
| 2 |
Invesco QQQ Trust
QQQ
|
$1.57M |
| 3 |
MiMedx Group
MDXG
|
$1.25M |
| 4 |
Apple
AAPL
|
$501K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$387K |
Sector Composition
| 1 | Healthcare | 21.23% |
| 2 | Technology | 15.58% |
| 3 | Financials | 10.38% |
| 4 | Consumer Discretionary | 1.55% |
| 5 | Communication Services | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Invesco QQQ Trust
QQQ
$359B
| $18.5M | 36.67% |
38,703
-3,269
| -8% | -$1.57M |
|
|
2
MiMedx Group
MDXG
$1.06B
| $6.36M | 12.57% |
917,343
-179,673
| -16% | -$1.25M |
|
|
3
Apple
AAPL
$3.39T
| $5.85M | 11.56% |
27,758
-2,381
| -8% | -$501K |
|
|
4
Berkshire Hathaway Class B
BRK.B
$1.08T
| $5.18M | 10.25% |
12,742
-951
| -7% | -$387K |
|
5
Guggenheim Strategic Opportunities Fund
GOF
$2.62B
| $4.43M | 8.75% |
296,824
-5,283
| -2% | -$78.8K |
|
6
Microsoft
MSFT
$3.73T
| $2.03M | 4.02% |
4,544
-577
| -11% | -$258K |
|
|
7
DURECT Corp
DRRX
$59.9M
| $1.38M | 2.74% |
1,072,014
+303,670
| +40% | +$392K |
|
|
8
Heron Therapeutics
HRTX
$205M
| $1.25M | 2.47% |
356,558
+59,852
| +20% | +$209K |
|
9
iShares Biotechnology ETF
IBB
$5.66B
| $1M | 1.98% |
7,290
-959
| -12% | -$132K |
|
10
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.53B
| $549K | 1.08% |
44,024
-1,826
| -4% | -$22.8K |
|
|
11
ProShares UltraPro QQQ
TQQQ
$24.9B
| $544K | 1.08% |
7,373
+1,760
| +31% | +$130K |
|
12
Amazon
AMZN
$2.39T
| $541K | 1.07% |
2,797
| – | – |
|
13
iShares Core S&P 500 ETF
IVV
$654B
| $494K | 0.98% |
902
-6
| -0.7% | -$3.28K |
|
14
Rockwell Medical
RMTI
$61.6M
| $487K | 0.96% |
276,828
-45,423
| -14% | -$79.9K |
|
15
Alphabet (Google) Class C
GOOG
$2.52T
| $364K | 0.72% |
1,984
| – | – |
|
|
AXNX
16
DELISTED
Axonics, Inc. Common Stock
AXNX
| $319K | 0.63% |
4,749
| – | – |
|
|
IRD
17
Opus Genetics, Inc. Common Stock
IRD
$77.9M
| $293K | 0.58% |
191,304
-36,157
| -16% | -$55.3K |
|
18
Applied Therapeutics
APLT
$71.9M
| $289K | 0.57% |
61,827
| – | – |
|
19
McDonald's
MCD
$224B
| $242K | 0.48% |
948
| – | – |
|
|
ONCT
20
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $188K | 0.37% |
24,696
| – | – |
|
|
21
Alvotech
ALVO
$2.51B
| $170K | 0.34% |
+13,966
| New | +$170K |
|
|
22
SoFi Technologies
SOFI
$29.7B
| $66.6K | 0.13% |
+10,083
| New | +$66.6K |
|
23
Verizon
VZ
$186B
| – | – |
-4,947
| Closed | -$208K |
|
24
Air Industries Group
AIRI
$14.9M
| – | – |
-34,805
| Closed | -$164K |
|
|
25
ARK Innovation ETF
ARKK
$7.36B
| – | – |
-31,639
| Closed | -$1.58M |
|